TRANSLATE

Welcome to Our Parkinson's Place


I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's
diseases as well and thought it would be nice to have a place where
updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please No advertisers, and No Information about Herbal treatments. This is a free site for all.
Thank you.


Thursday, June 29, 2017

FoxFeed Blog: MJFF Scientist Highlights Alpha-synuclein Research Progress in Nature Reviews Drug Discovery

By  Kristen Teesdale,  June 29, 2017



As researchers search for a therapy to slow or stop Parkinson's disease (PD) progression, alpha-synuclein has emerged as a leading target. This protein clumps in the brains of nearly everyone with Parkinson's and it's the primary component of Lewy bodies, the pathological hallmark of PD. At the current time, five therapies representing varied approaches against alpha-synuclein are in different stages of clinical trial testing.
In an interview for Nature Reviews Drug Discovery, Brian Fiske, PhD, senior vice president of research programs at MJFF, discussed the field's focus on alpha-synuclein. "The real unmet medical need [in Parkinson's] is a treatment that can target the underlying disease mechanism and can slow and ultimately halt the disease process. That's where the excitement around targets like a-synuclein comes from."
http://www.readcube.com/articles/10.1038/nrd.2017.95?shared_access_token=X_NzUw7vu4_cNX_TEJtn69RgN0jAjWel9jnR3ZoTv0MS9PnCoWe_UuQ5GUohdo8M22W0grgKbbY0Rjxk-Vz1YYT1UTtOMNWc3SksCsfsmTh4xco4oNZrI_E7NGyViQhYjiobKCbl_-7CDRPQM8QAJA%3D%3D

https://www.michaeljfox.org/foundation/news-detail.php?mjff-scientist-highlights-alpha-synuclein-research-progress-in-nature-reviews-drug-discovery

No comments:

Post a Comment